Membership
IBMI
  Pharmaceutical / Biotechnology
Sinphar Pharmaceutical Co., Ltd.
Sinphar Pharmaceutical Co., Ltd. was founded by Mr. Lee in 1977 with the vision of upholding the purpose of “life, health, and technology”, exploring the key to life through scientific methods, and promoting human health. Since 1997, the Sinphar Group started its global footprint. Its subsidiaries include SynCore Biotechnology, ZuniMed Biotech, CanCap Pharmaceutical (Canada) and Sinphar Tianli (Hangzhou) Pharmaceutical. Under a rigorous organizational structure, it integrates professional pharmaceutical and R&D technologies to form an international pharmaceutical group involved in new drugs, generic drugs, health food, cosmeceuticals, and medical devices, and its products are sold in more than 20 countries around the world.
Information appearing on this website (images and texts, unless otherwise indicated) is the property of IBMI. To use or share, please indicate the source.
© 2026 Institute for Biotechnology and Medicine Industry (IBMI) All rights reserved.
Address:9F., No. 508, Sec. 7, Zhongxiao E. Rd., Nangang Dist., Taipei City , Taiwan (R.O.C.) Contact Number:(02)2655-8168 Fax:(02)2655-7978